Increased NGS throughput for personalized genomics with automated cell counting
Sangmi Han discusses how cell counters have become an integral part of Macrogen’s single-cell RNA sequencing workflow
Sangmi Han discusses how cell counters have become an integral part of Macrogen’s single-cell RNA sequencing workflow
Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine
From Alzheimer’s disease to 3D brain modeling: Watch top speakers and connect with leading neuroscience innovators online, November 17-18
Join us Monday, November 16, to explore the advantages and applications of direct molecular testing
Which new products made the most difference to your lab work this year?
The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance
Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies
The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy
Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience
Join us Thursday, November 5, to learn how to introduce base editing technology into your cell therapy pipeline
The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients
Join us Tuesday, October 13, to hear from the multiplexing experts behind our four-part digital pathology webinar series
The Royal Swedish Academy of Sciences awards Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for genome editing
Explore our roundup of key considerations for a successful CRISPR/Cas9 experiment
The study has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumors
Watch this on-demand webinar to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq
Meet the researchers making waves in science and learn about the technologies innovating their research
Connecting the scientific community with two new online content-packed events
The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes